Compounds > rotenone
Page last updated: 2024-08-17

rotenone and Catatonic Rigidity

rotenone has been researched along with Catatonic Rigidity in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cannon, JR; Drolet, RE; Greenamyre, JT; Honick, AS; Na, HM; Tapias, V1
Alam, M; Danysz, W; Dekundy, A; Schmidt, WJ1
Alam, M; Schmidt, WJ1

Other Studies

3 other study(ies) available for rotenone and Catatonic Rigidity

ArticleYear
A highly reproducible rotenone model of Parkinson's disease.
    Neurobiology of disease, 2009, Volume: 34, Issue:2

    Topics: alpha-Synuclein; Animals; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Hypokinesia; Injections, Intraperitoneal; Male; Muscle Rigidity; Nerve Degeneration; Neurons; Neurotoxins; Parkinsonian Disorders; Rats; Rats, Inbred Lew; Reproducibility of Results; Rotenone; Substantia Nigra; Tyrosine 3-Monooxygenase; Ubiquitins; Uncoupling Agents

2009
Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
    Toxicology and applied pharmacology, 2009, Oct-15, Volume: 240, Issue:2

    Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Basal Ganglia; Behavior, Animal; Catalepsy; Cyclopentanes; Disease Models, Animal; Dopamine; Excitatory Amino Acid Antagonists; Hypokinesia; Idazoxan; Male; Motor Activity; Muscle Rigidity; Neuroprotective Agents; Neurotoxicity Syndromes; Parkinsonian Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Adrenergic, alpha-2; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Rotenone; Serotonin; Substantia Nigra; Time Factors

2009
L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats.
    Behavioural brain research, 2004, Aug-31, Volume: 153, Issue:2

    Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Corpus Striatum; Dopamine; Drug Synergism; Electron Transport Complex I; Levodopa; Male; Motor Activity; Motor Skills; Muscle Rigidity; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Uncoupling Agents

2004